首頁 > 市場調查報告書 > 製藥

藥物開發

藥物發現資訊學市場規模、佔有率和成長分析（按功能、應用、解決方案、最終用戶和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1897939

藥物發現資訊學市場規模、佔有率和成長分析（按功能、應用、解決方案、最終用戶和地區分類）—產業預測，2026-2033年

Drug Discovery Informatics Market Size, Share, and Growth Analysis, By Function (Sequencing and Target Data Analysis, Docking), By Application (Drug Discovery, Drug Development), By Solution, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球藥物發現資訊學市場預計到 2024 年將達到 36.6 億美元，到 2025 年將達到 40.7 億美元，到 2033 年將達到 95.9 億美元，在預測期（2026-2033 年）內複合年成長率為 11.3%。

全球藥物發現資訊學市場正經歷顯著成長，這主要得益於對罕見疾病和孤兒藥研發的日益重視，以及生物技術和製藥業對資訊投入的不斷增加。研發支出的激增表明市場對藥物發現資訊學的強勁需求，包括製藥公司利用綜合藥物和化合物資料庫進行廣泛的數據收集。先進的軟體能夠實現高效的資料庫管理和分析，從而應對藥物發現過程中的各種挑戰。高效能運算、增強的雲端服務以及資訊學軟體的應用進一步推動了市場擴張。儘管對新型療法的需求不斷成長以及In Silico模擬技術的應用是積極的促進因素，但資訊學工具的高成本構成了潛在的障礙。然而，發展中地區生物技術的蓬勃發展帶來了寶貴的機會。

全球藥物發現資訊學市場促進因素

全球藥物發現資訊學市場的發展主要得益於技術的顯著進步，尤其是在人工智慧 (AI) 和機器學習領域。這些創新提升了數據分析能力，使研究人員能夠有效率且精準地管理大量數據。這種效率的提升顯著簡化了適用於藥物開發的分子實體的識別，並加速了整個藥物發現過程。借助這些最尖端科技，研究人員可以做出更明智的決策，推動創新，最終帶來更有效的治療方法和更優質的醫療保健。這些技術的融合標誌著藥物發現方式的轉捩點，並將徹底改變藥物發現的進行方式。

全球藥物發現資訊學市場面臨的限制因素

全球藥物研發資訊學市場面臨的主要挑戰之一是對資料保護的重視以及遵守各項法律法規的必要性。遵守諸如GDPR等隱私法規使得重要研究資料的管理和共用變得複雜。這種法規環境阻礙了研究人員之間的有效合作，並限制了創新資訊學解決方案的應用。因此，嚴格的資料保護措施阻礙了藥物研發活動的進展，最終抑制了產業成長，並降低了企業投資該領域新技術的動機。

全球藥物發現資訊學市場趨勢

全球藥物研發資訊學市場正呈現出顯著趨勢，這主要得益於人工智慧和機器學習技術的日益普及。這些先進工具正在革新數據分析，能夠更快地識別候選藥物並增強預測建模能力。這種變革不僅加速了藥物研發進程，也推動了產業的創新和效率提升。隨著各機構利用這些技術，他們能夠簡化工作流程、降低成本並改善團隊合作，最終重塑藥物研發格局。在競爭日益激烈的市場中，強大的運算能力和數據驅動的洞察力正成為企業成功的關鍵因素。

IBM（United States）
Infosys Limited（India）
Thermo Fisher Scientific（United States）
PerkinElmer Inc.（United States）
Schrodinger, Inc.（United States）
Charles River Laboratories International, Inc.（United States）
Certara, Inc.（United States）
Accenture plc（Ireland）
Agilent Technologies, Inc.（United States）
Illumina, Inc.（United States）
Dassault Systemes SE（France）
Collaborative Drug Discovery, Inc.（United States）
Eurofins DiscoverX Products（United States）
Jubilant Biosys Limited（India）
Selvita SA（Poland）
Novo Informatics Pvt. Ltd.（India）
ChemAxon Ltd.（Hungary）
Albany Molecular Research Inc.（United States）
Boehringer Ingelheim GmbH（Germany）
Oracle Corporation（United States）

結論與建議

簡介目錄

Product Code: SQMIG35I2209

Global Drug Discovery Informatics Market size was valued at USD 3.66 Billion in 2024 and is poised to grow from USD 4.07 Billion in 2025 to USD 9.59 Billion by 2033, growing at a CAGR of 11.3% during the forecast period (2026-2033).

The global drug discovery informatics market is witnessing significant growth driven by the rising focus on rare diseases and orphan drug development, alongside increased investment in informatics by biotechnology and pharmaceutical sectors. This surge in research spending indicates robust demand for drug discovery informatics, which encompasses extensive data gathering facilitated by comprehensive medication and compound databases utilized by pharmaceutical companies. Advanced software enables efficient database management and analysis, addressing various challenges within the discovery process. Enhancements in high-performance computing, cloud services, and the use of informatics software are further propelling market expansion. Increasing demand for novel therapeutic agents and the adoption of in silico modeling technologies contribute positively, while the high costs of informatics tools present potential barriers. However, the growth of biotechnology in developing regions presents valuable opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Informatics Market Segments Analysis

Global Drug Discovery Informatics Market is segmented by Function, Application, Solution, End User and region. Based on Function, the market is segmented into Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation and Other functions. Based on Application, the market is segmented into Drug Discovery and Drug Development. Based on Solution, the market is segmented into Software and Services. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Informatics Market

The global drug discovery informatics market is being propelled by significant technological advancements, especially in artificial intelligence and machine learning. These innovations enhance data analysis capabilities, enabling researchers to efficiently manage vast amounts of data with remarkable accuracy. This efficiency significantly streamlines the identification of molecular entities suitable for drug development, thereby expediting the overall drug discovery process. As researchers harness these cutting-edge technologies, they can make more informed decisions and drive innovation, ultimately leading to more effective therapies and improved healthcare outcomes. The integration of these technologies marks a transformative shift in how drug discovery is conducted.

Restraints in the Global Drug Discovery Informatics Market

One significant challenge facing the global drug discovery informatics market is the emphasis on data protection and the necessity to adhere to various legal requirements. Compliance with privacy regulations, such as GDPR, complicates the management and sharing of crucial research data. This regulatory environment hampers researchers' ability to collaborate effectively and limits the adoption of innovative informatics solutions. Consequently, the stringent data protection measures pose barriers to progress in drug discovery efforts, ultimately stifling growth and reducing companies' willingness to invest in new technological advancements in this field.

Market Trends of the Global Drug Discovery Informatics Market

The Global Drug Discovery Informatics market is witnessing a significant trend driven by the increasing adoption of AI and Machine Learning technologies. These advanced tools are revolutionizing data analysis, enabling faster identification of drug candidates and enhancing predictive modeling capabilities. This shift not only accelerates the drug discovery process but also stimulates innovation and efficiency within the industry. As organizations leverage these technologies, they are able to streamline workflows, reduce costs, and improve collaboration across teams, ultimately reshaping the landscape of pharmaceutical research and development. The enhanced computational power and data-driven insights are becoming essential for success in an increasingly competitive market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis
Patent Analysis

Global Drug Discovery Informatics Market Size by Function & CAGR (2026-2033)

Market Overview
Sequencing and Target Data Analysis
Docking
Molecular Modelling
Library & Database Preparation
Other functions

Global Drug Discovery Informatics Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery
Drug Development
- Preclinical Testing
- Clinical Trials

Global Drug Discovery Informatics Market Size by Solution & CAGR (2026-2033)

Market Overview
Software
Services

Global Drug Discovery Informatics Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organization (CROs)
Other End Users

Global Drug Discovery Informatics Market Size & CAGR (2026-2033)

North America (Function, Application, Solution, End User)
- US
- Canada
Europe (Function, Application, Solution, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Function, Application, Solution, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Function, Application, Solution, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Function, Application, Solution, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

IBM (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Infosys Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schrodinger, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Certara, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accenture plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dassault Systemes SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collaborative Drug Discovery, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins DiscoverX Products (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Biosys Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Selvita S.A. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Informatics Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ChemAxon Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Albany Molecular Research Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments